The dawn of aspirin free strategy after short term dual antiplatelet for percutaneous coronary intervention: meta-analysis of randomized controlled trials
Published in
Journal of Thrombosis and Thrombolysis, November 2019
Pharmacology, Toxicology and Pharmaceutical Science
1
4%
Business, Management and Accounting
1
4%
Unknown
12
48%
Attention Score in Context
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 June 2020.
All research outputs
#6,860,060
of 23,177,498 outputs
Outputs from Journal of Thrombosis and Thrombolysis
#298
of 997 outputs
Outputs of similar age
#145,973
of 457,712 outputs
Outputs of similar age from Journal of Thrombosis and Thrombolysis
#11
of 29 outputs
Altmetric has tracked 23,177,498 research outputs across all sources so far. This one has received more attention than most of these and is in the 70th percentile.
So far Altmetric has tracked 997 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has gotten more attention than average, scoring higher than 70% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 457,712 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.
We're also able to compare this research output to 29 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.
